DOI:
10.1055/s-00000049
Clinics in Colon and Rectal Surgery
LinksClose Window
References
Miranda C, Nucifora M, Molinari F. , et al.
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors.
Clin Cancer Res 2012;
18 (06) 1769-1776
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.